Gilboa M, Mandelboim M, Indenbaum V, Lustig Y, et al. Early Immunogenicity and safety of the third dose of BNT162b2 mRNA Covid-19 vaccine among adults older than 60 years; real world experience. J Infect Dis 2021 Nov 29. pii: 6446235. doi: 10.1093.
PMID: 34850049